Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder
The DOI matches its Crossref record.
Abstract
BACKGROUND: Acute dissociative states are common in patients with borderline personality disorder (BPD). However, there are no established pharmacotherapeutic treatment options for this severe clinical condition. METHODS: The effect of 0.4 mg naloxone administered intravenously in acute dissociative states was examined as compared to placebo in a double-blind crossover study in nine patients who met DSM-IV-criteria for BPD. Dissociative symptoms before and 15 min after a single dose of naloxone or saline placebo were assessed using a self-rating instrument for dissociation and aversive inner tension (DSS) and the observer-based items of the Clinician Administered Dissociative States Scale (CADSS). RESULTS: Dissociative symptoms before treatment with naloxone or saline placebo were moderate to severe. After injection of either naloxone or placebo, dissociative symptoms significantly decreased on the DSS (p < 0.01) and the CADSS (p < 0.05). However, there were no significant differences between naloxone and placebo in the reduction of symptoms. Patients who showed the most prominent response to naloxone fulfilled the highest number of DSM-IV-criteria for BPD. CONCLUSIONS: Although it is difficult to draw definite conclusions from this small sample of patients, this study does not support the assumption that naloxone in a single dose of 0.4 mg is superior to placebo in acute dissociative states in patients with BPD. Further studies will investigate whether patients benefit from naloxone in a higher dose or whether subgroups of patients with BPD profit from naloxone in acute dissociative states.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Lanius, R. A., Brand, B., Vermetten, E., Frewen, P. A., & Spiegel, D. (2012) · Depression and Anxiety · doi:10.1002/da.21889 · Cited by 459
“[38] Opioid antagonists, including naltrexone and naloxone also have been explored as a pharmacotherapeutic treatment option for dissociative symptomatology.[39, 40] However, there have been few placebo-controlled pharmacotherapeutic trials for dissociative symptoms, and no specific antidissociative drugs have been de…”
BackgroundPharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
Self-citationBorderline personality disorder: a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010) · Psychological Review · doi:10.1037/a0018095 · Cited by 135
Ludäscher, P., Valerius, G., Stiglmayr, C., Mauchnik, J., Lanius, R. A., Bohus, M., & Schmahl, C. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090022 · Cited by 131
Self-citationDuggan, C., Huband, N., Smailagic, N., Ferriter, M., & Adams, C. (2007) · Personality and Mental Health · doi:10.1002/pmh.22 · Cited by 117
Metadata
- Authors
- Philipsen, A., Schmahl, C., & Lieb, K.
- Affiliations
- University of Freiburg (DE)
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2004-09
- Volume
- 37
- Issue
- 5
- Pages
- 196-199
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2009952140
- Cited by
- 80
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 7 · 2012: 4
- FWCI
- 5.20
- Type
- journal article
- Language
- de
- Open access
- closed
- Locations
- Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- naloxone, borderline personality disorder, dissociative states, female patients, intravenous administration, dissociation, placebo comparison, pharmacotherapy
- MeSH terms
- Acute Disease, Adult, Borderline Personality Disorder, Dissociative Disorders, Double-Blind Method, Female, Humans, Injections, Intravenous, Naloxone, Narcotic Antagonists, Severity of Illness Index, Cross-Over Studies, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder. https://app.cochat.ai/papers/10.1055/s-2004-827243
- The paper
- Philipsen, A., Schmahl, C., & Lieb, K. (2004). Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder. Pharmacopsychiatry. https://doi.org/10.1055/s-2004-827243
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.